Product Images Nifedipine

This is a description of medication, specifically NIFEdipine with a 30mg dosage. The medication is in tablet form and is manufactured by Ingenus located in Fairfield, NJ with an NDC number of 70518-2679-00. The LOT number and expiration date are not available. The medication should be kept out of reach from children and should be swallowed whole, not bitten or divided. The package insert should be consulted for directions on use. The medication should be stored at a temperature between 20-26°C (63-77°F) with excursions allowed up to 15-30°C (59-86°F) as per USP guidelines. The remaining text is not legible.*

This text provides information about the side effects of Nifedipine extended-release tablets. The table shows the percentage of patients (N=707) who experienced adverse effects such as headache, fatigue, dizziness, constipation, and nausea. It also compares the percentage of patients who experienced similar effects while taking a placebo (N=266).*

This is a table showing the percentage of adverse effects experienced by participants taking Nifedipine Capsules compared to those taking a placebo. The adverse effects listed include dizziness, lightheadedness, giddiness, flushing, heat sensation, headache, weakness, nausea, heartburn, muscle cramps, tremor, peripheral edema, nervousness, mood changes, palpitations, dyspnea, cough, wheezing, nasal congestion, and sore throat. The number of participants in each group (N=226 for the Nifedipine group and N=235 for the placebo group) is also included in the table.*